• Article

Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial Fibrillation [MEETING ABSTRACT PCV68]

Citation

Barrett, A., DiBenedetti, D., Phatak, H., Masseria, C., & Kamble, S. (2016). Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial Fibrillation [MEETING ABSTRACT PCV68]. Value in Health, 19(3), A51-A51. DOI: 10.1016/j.jval.2016.03.168

Abstract

Established OAC users reported being satisfied and perceived their OAC as effective with low bleeding risk. Users who switched from warfarin to a NOAC reported increased satisfaction related to the lack of clotting-time testing and no dietary restrictions. All OAC users reported dissatisfaction related to worry about bleeding risk.